# reload+after+2024-01-20 23:46:09.239972
address1§320 Wakara Way
city§Salt Lake City
state§UT
zip§84108
country§United States
phone§801 584 3600
fax§801 584 3640
website§https://myriad.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§Myriad Genetics, Inc., a genetic testing and precision medicine company, develops genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It also provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, or metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic Test, a RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic Test, a RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor, a solution for precision oncology; and Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus. Further, it provides Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; and GeneSight Psychotropic Mental Health Medication Test, a DNA genotyping test to aid psychotropic drug selection for patients suffering from depression, anxiety, ADHD, and other mental health conditions. Myriad Genetics, Inc. has a strategic collaboration with Illumina, Inc. and Intermountain Precision Genomics. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.
fullTimeEmployees§2600
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Paul J. Diaz', 'age': 61, 'title': 'CEO, President & Director', 'yearBorn': 1962, 'fiscalYear': 2022, 'totalPay': 1877527, 'exercisedValue': 0, 'unexercisedValue': 423153}, {'maxAge': 1, 'name': 'Mr. R. Bryan Riggsbee', 'age': 52, 'title': 'Executive VP, CFO & Treasurer', 'yearBorn': 1971, 'fiscalYear': 2022, 'totalPay': 845147, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Kevin Richard Haas Ph.D.', 'age': 37, 'title': 'Chief Technology Officer', 'yearBorn': 1986, 'fiscalYear': 2022, 'totalPay': 580360, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mark S. Verratti', 'age': 55, 'title': 'Chief Commercial Officer', 'yearBorn': 1968, 'fiscalYear': 2022, 'totalPay': 794847, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Nicole  Lambert', 'age': 49, 'title': 'Consultant', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 746912, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Samraat S. Raha', 'age': 50, 'title': 'Chief Operating Officer', 'yearBorn': 1973, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Natalie  Munk', 'age': 42, 'title': 'Principal Accounting Officer', 'yearBorn': 1981, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Dale  Muzzey Ph.D.', 'age': 43, 'title': 'Chief Scientific Officer', 'yearBorn': 1980, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Matthew  Scalo', 'title': 'Senior Vice President of Investor Relations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Pamela  Wong', 'age': 55, 'title': 'Chief Legal Officer', 'yearBorn': 1968, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§10
boardRisk§1
compensationRisk§3
shareHolderRightsRisk§5
overallRisk§5
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.926
priceToSalesTrailing12Months§2.1470006
currency§USD
dateShortInterest§1702598400
forwardEps§0.0
pegRatio§7.28
exchange§NMS
quoteType§EQUITY
shortName§Myriad Genetics, Inc.
longName§Myriad Genetics, Inc.
firstTradeDateEpochUtc§812986200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§a15ca704-b4ab-351f-8b50-c0bf16b137c5
gmtOffSetMilliseconds§-18000000
targetHighPrice§28.0
targetLowPrice§12.0
targetMeanPrice§21.54
targetMedianPrice§23.0
recommendationMean§2.7
recommendationKey§hold
numberOfAnalystOpinions§12
quickRatio§0.963
grossMargins§0.68886
ebitdaMargins§-0.13576001
trailingPegRatio§None
